• Citer

Correlation of PIK3CA mutation with pathological complete response in primary HER2-positive breast cancer: Combined analysis of 967 patients from three prospective clinical trials.

par Loibl, Sibylle;Majewski, Ian IJ;Guarneri, V;Nekljudova, Valentina;McCormick Holmes, E;Bria, E;Denkert, Carsten;Eidtmann, H.;Sotiriou, Christos ;Loi, Sherene ;Andre, Fabrice;Untch, Michael;Conte, PierFranco;Piccart-Gebhart, Martine ;Von Minckwitz, Gunter;Baselga, José
Référence 2015 ASCO Annual Meeting(May 29 - June 2, 2015: Chicago, Il, USA), Journal of Clinical Oncology Supplement, 2015 ASCO Annual Meeting abstracts, Vol. Volume 33, Issue 15_suppl
Publication Publié, 2015-05-20

Abstract de conférence

• Détails

Titre:	Correlation of PIK3CA mutation with pathological complete response in primary HER2-positive breast cancer: Combined analysis of 967 patients from three prospective clinical trials.
Auteur:	Loibl, Sibylle; Majewski, Ian IJ; Guarneri, V; Nekljudova, Valentina; McCormick Holmes, E; Bria, E; Denkert, Carsten; Eidtmann, H.; Sotiriou, Christos; Loi, Sherene; Andre, Fabrice; Untch, Michael; Conte, PierFranco; Piccart-Gebhart, Martine; Von Minckwitz, Gunter; Baselga, José
Informations sur la publication:	2015 ASCO Annual Meeting(May 29 - June 2, 2015: Chicago, Il, USA), Journal of Clinical Oncology Supplement, 2015 ASCO Annual Meeting abstracts, Vol. Volume 33, Issue 15_suppl
Statut de publication:	Publié, 2015-05-20
Sujet CREF:	Cancérologie
	Médecine pathologie humaine
	Sciences bio-médicales et agricoles
Note générale:	Clinical Science Symposium, Predicting Response in Triple-Negative and HER2-Positive Breast Cancer: Unlocking Pieces to Solve the Puzzles. J Clin Oncol 33, 2015 (suppl; abstr 511)
Langue:	Anglais